Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study

N. Ortonne; L. Valeyrie-Allanore; S. Bastuji-Garin; J. Wechsler; S. de Feraudy; T.-A. Duong; M.-H. Delfau-Larue; O. Chosidow; P. Wolkenstein; J.-C. Roujeau

doi:10.1111/bjd.13683

journal article Apr 16, 2015

Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study

N. Ortonne L. Valeyrie-Allanore S. Bastuji-Garin J. Wechsler S. de Feraudy T.-A. Duong

M.-H. Delfau-Larue O. Chosidow P. Wolkenstein J.-C. Roujeau

British Journal of Dermatology Vol. 173 No. 1 pp. 50-58 · Oxford University Press (OUP)

View at Publisher Save 10.1111/bjd.13683

Topics

No keywords indexed for this article. Browse by subject →

References

21

[1]

Ben m'rad "Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients" Medicine (Baltimore) (2009) 10.1097/md.0b013e3181a4d1a1

[2]

Kardaun "Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study" Br J Dermatol (2013) 10.1111/bjd.12501

[3]

Tohyama "Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome" Br J Dermatol (2007) 10.1111/j.1365-2133.2007.08167.x

[4]

Seishima "Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome" Br J Dermatol (2006) 10.1111/j.1365-2133.2006.07332.x

[5]

Shiohara "Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses" Allergol Int (2006) 10.2332/allergolint.55.1

[6]

Weedon (2010)

[7]

Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS)

M.-H. Chi, R.C.-Y. Hui, C.-H. Yang et al.

British Journal of Dermatology 2014 10.1111/bjd.12783

[8]

Chiou "Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan" J Eur Acad Dermatol Venereol (2008) 10.1111/j.1468-3083.2008.02585.x

[9]

Walsh "Drug reaction with eosinophilia and systemic symptoms (DRESS): is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases" Br J Dermatol (2013) 10.1111/bjd.12081

[10]

Cordel "Study of the clonality of cutaneous and blood lymphocytes during drug-induced hypersensitivity in 6 patients" Ann Dermatol Venereol (2004) 10.1016/s0151-9638(04)93841-0

[11]

Chung "Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis" Nat Med (2008) 10.1038/nm.1884

[12]

Picard "Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response" Sci Transl Med (2010) 10.1126/scitranslmed.3001116

[13]

Takahashi "Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome" J Immunol (2009) 10.4049/jimmunol.0804002

[14]

Kardaun "Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?" Br J Dermatol (2007) 10.1111/j.1365-2133.2006.07704.x

[15]

Delfau-Larue "Value of clonality studies of cutaneous T lymphocytes in the diagnosis and follow-up of patients with mycosis fungoides" J Pathol (1998) 10.1002/(sici)1096-9896(199802)184:2<185::aid-path997>3.0.co;2-9

[16]

Bourgeois "A review of DRESS-associated myocarditis" J Am Acad Dermatol (2011) 10.1016/j.jaad.2010.11.057

[17]

McKee (2005)

[18]

Elder (2009)

[19]

Yawalkar "Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions" Clin Exp Allergy (2000) 10.1046/j.1365-2222.2000.00847.x

[20]

Gerson "Cutaneous drug eruptions: a 5-year experience" J Am Acad Dermatol (2008) 10.1016/j.jaad.2008.09.015

[21]

Mizukawa "In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption" Br J Dermatol (2008) 10.1111/j.1365-2133.2008.08516.x

Cited By

118

Severe cutaneous adverse reactions to drugs

Tu Anh Duong, Laurence Valeyrie-Allanore · 2017

The Lancet

Metrics

118

Citations

21

References

Details

Published: Apr 16, 2015
Vol/Issue: 173(1)
Pages: 50-58
License: View

Authors

N

N. Ortonne

Département de Pathologie; Assistance Publique - Hôpitaux de Paris (AP-HP); Hôpital Henri-Mondor; 94010 Créteil Cedex France; INSERM U955 équipe 9; Hôpital Henri-Mondor; 94010 Créteil Cedex France; Université Paris Est Créteil (UPEC); Faculté de Médecine, LIC EA4393; 94010 Créteil Cedex France

L

L. Valeyrie-Allanore

Université Paris Est Créteil (UPEC); Faculté de Médecine, LIC EA4393; 94010 Créteil Cedex France; Service de Dermatologie; Assistance Publique - Hôpitaux de Paris (AP-HP); Hôpital Henri-Mondor; 94010 Créteil Cedex France

S

S. Bastuji-Garin

Université Paris Est Créteil (UPEC); Faculté de Médecine, LIC EA4393; 94010 Créteil Cedex France; Service de Santé-Publique; Assistance Publique - Hôpitaux de Paris (AP-HP); Hôpital Henri-Mondor; 94010 Créteil Cedex France

J

J. Wechsler

Département de Pathologie; Assistance Publique - Hôpitaux de Paris (AP-HP); Hôpital Henri-Mondor; 94010 Créteil Cedex France

S

S. de Feraudy

Département de Pathologie; Assistance Publique - Hôpitaux de Paris (AP-HP); Hôpital Henri-Mondor; 94010 Créteil Cedex France

T

T.-A. Duong

Université Paris Est Créteil (UPEC); Faculté de Médecine, LIC EA4393; 94010 Créteil Cedex France; Service de Dermatologie; Assistance Publique - Hôpitaux de Paris (AP-HP); Hôpital Henri-Mondor; 94010 Créteil Cedex France

M

M.-H. Delfau-Larue

INSERM U955 équipe 9; Hôpital Henri-Mondor; 94010 Créteil Cedex France; Université Paris Est Créteil (UPEC); Faculté de Médecine, LIC EA4393; 94010 Créteil Cedex France; Service d'Immunologie Biologique; Assistance Publique - Hôpitaux de Paris (AP-HP); Hôpital Henri-Mondor; 94010 Créteil Cedex France

O

O. Chosidow

Université Paris Est Créteil (UPEC); Faculté de Médecine, LIC EA4393; 94010 Créteil Cedex France; Service de Dermatologie; Assistance Publique - Hôpitaux de Paris (AP-HP); Hôpital Henri-Mondor; 94010 Créteil Cedex France

P

P. Wolkenstein

Université Paris Est Créteil (UPEC); Faculté de Médecine, LIC EA4393; 94010 Créteil Cedex France; Service de Dermatologie; Assistance Publique - Hôpitaux de Paris (AP-HP); Hôpital Henri-Mondor; 94010 Créteil Cedex France

J

J.-C. Roujeau

Université Paris Est Créteil (UPEC); Faculté de Médecine, LIC EA4393; 94010 Créteil Cedex France

Cite This Article

N. Ortonne, L. Valeyrie-Allanore, S. Bastuji-Garin, et al. (2015). Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study. British Journal of Dermatology, 173(1), 50-58. https://doi.org/10.1111/bjd.13683

Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study

You May Also Like